Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History

被引：5
作者：
Jentzen, Walter [1 ]
Nahum, Alan E. [1 ]
Bockisch, Andreas [1 ]
Binse, Ina [1 ]
Tulchinsky, Mark [1 ]
机构：
[1] Klin Nukl Med, Hufelandstr 55, D-45122 Essen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷 / 09期
关键词：
RADIOIODINE THERAPY;
D O I：
10.2967/jnumed.117.192872
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1530 / 1530
页数：1
相关论文
共 37 条
[31]   Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer [J].
Sgouros, George ;
Hobbs, Robert F. ;
Atkins, Francis B. ;
Van Nostrand, Douglas ;
Ladenson, Paul W. ;
Wahl, Richard L. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 :41-47
[32]   Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching [J].
Liu, Ye ;
Wang, Yuhua ;
Zhang, Wanchun .
FRONTIERS IN SURGERY, 2022, 9
[33]   Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer [J].
Walter Jentzen ;
Robert F. Hobbs ;
Alexander Stahl ;
Jochen Knust ;
George Sgouros ;
Andreas Bockisch .
European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 :884-895
[34]   Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer [J].
Jentzen, Walter ;
Hobbs, Robert F. ;
Stahl, Alexander ;
Knust, Jochen ;
Sgouros, George ;
Bockisch, Andreas .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) :884-895
[35]   Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study [J].
Carrillo, Jose F. ;
Vazquez-Romo, Rafael ;
Ramirez-Ortega, Margarita C. ;
Carrillo, Liliana C. ;
Gomez-Argumosa, Edgar ;
Onate-Ocana, Luis F. .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[36]   BRAF V600E mutation in papillary thyroid cancer and its effect on postoperative radioiodine (131I) therapy: Should we modify our therapeutic strategy? [J].
Dominguez Ayala, Maite ;
Exposito Rodriguez, Amaia ;
Bilbao Gonzalez, Amaia ;
Minguez Gabina, Pablo ;
Gutierrez Rodriguez, Teresa ;
Rodeno Ortiz de Zarate, Emilia ;
Garcia Carrillo, Maitane ;
Barrios Trevino, Borja .
CIRUGIA ESPANOLA, 2018, 96 (05) :276-282
[37]   Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate-to-High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients [J].
Lee, Jeong Won ;
Lee, Sang Mi ;
Lee, Dae Ho ;
Kim, Yeo Joo .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) :1230-1236
1234